Showing results (1721-1730 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 2, 2011
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial dataJames G Xenakis, Elizabeth T Kinter, K Jack Ishak, et al.Pharmacoeconomics|May 12, 2011
Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic reviewAlexander Goehler, Benjamin P Geisler, Jennifer M Manne, et al.Pharmacoeconomics|December 6, 2011
Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisalClaire McKenna, Emma Maund, Muhammad Sarowar, et al.Pharmacoeconomics|October 5, 2011
Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancerRobert I Griffiths, Richard L Barron, Michelle L Gleeson, et al.Pharmacoeconomics|November 15, 2011
Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspectiveHelen Dakin, Morris Sherman, Scott Fung, et al.Pharmacoeconomics|July 10, 2009
Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off methodHans-Helmut König, Oliver H Günther, Matthias C Angermeyer, et al.Pharmacoeconomics|December 29, 2011
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic reviewMathilda L Bongers, Veerle M H Coupé, Elise P Jansma, et al.Pharmacoeconomics|September 5, 2008
The NICE cost-effectiveness threshold: what it is and what that meansChristopher McCabe, Karl Claxton, Anthony J CulyerPharmacoeconomics|September 17, 2008
Quality-of-life assessment in rheumatoid arthritisAnthony S RussellPageof 336